Industry Insight
Information, Observation & Analysis
FPM AI platforms are innovating individualized treatment plans for cancer patients.
Artificial pancreas (AP) technology show the promise of improved glucose control, reduced hypoglycemic episodes and prevention of long-term complications for type 1 diabetes patients.
The HHS awards will support 158 new and existing health centers and expand access to primary care.
AI reliability in clinical decision support has grown in the past five years, but human oversight is still necessary.
Attention deficit hyperactivity disorder (ADHD) presents in different ways, requiring a thorough approach to diagnosis and treatment options.
Empathy can decline during clinical training, but research shows it may be a skill that can be taught.
More research is needed to understand why overactive mast cells trigger allergy-like reactions in this rare condition.
Cancer vaccines are proving to be a pillar of personalized treatment.
While there are many vaccines, not every promising vaccine has progressed to market, such as the vaccine for West Nile virus.
ODRescue's mission is to make naloxone readily available to combat opioid overdose deaths.